These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8347912)

  • 1. Use of hydroquinone as a bleaching cream.
    Yi K; Hart LL
    Ann Pharmacother; 1993 May; 27(5):592-3. PubMed ID: 8347912
    [No Abstract]   [Full Text] [Related]  

  • 2. Cosmetic and dermatology: bleaching creams.
    Engasser PG; Maibach HI
    J Am Acad Dermatol; 1981 Aug; 5(2):143-7. PubMed ID: 7021611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream.
    Baliña LM; Graupe K
    Int J Dermatol; 1991 Dec; 30(12):893-5. PubMed ID: 1816137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Confetti-like dyschromia caused by a bleaching cream containing hydroquinone in racially pigmented patients].
    Haas N
    Med Klin (Munich); 1988 May; 83(11):385-6, 390. PubMed ID: 3405155
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical use of hydroquinone for depigmentation.
    Spencer MC
    JAMA; 1965 Nov; 194(9):962-4. PubMed ID: 5897964
    [No Abstract]   [Full Text] [Related]  

  • 6. [Double-blind clinical study of the treatment of melasma with azelaic acid versus hydroquinone].
    Piquero Martín J; Rothe de Arocha J; Beniamini Loker D
    Med Cutan Ibero Lat Am; 1988; 16(6):511-4. PubMed ID: 3073279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Practical experiences with a hydroquinone monobenzylether preparation and a sunscreening agent in hyperpigmentations and light dermatoses].
    Jung HD
    Z Haut Geschlechtskr; 1967 Sep; 42(17):711-6. PubMed ID: 5593108
    [No Abstract]   [Full Text] [Related]  

  • 8. [Exogenous ochronosis, a little-known side effect of hydroquinone-containing ointments].
    Menke HE; Dekker SK; Noordhoek Hegt V; Pavel S; Westerhof W
    Ned Tijdschr Geneeskd; 1992 Jan; 136(4):187-90. PubMed ID: 1736131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroquinone and psoralens in the therapy of hypermelanosis and vitiligo.
    Fitzpatrick TB; Arndt KA; el-Mofty AM; Pathak MA
    Arch Dermatol; 1966 May; 93(5):589-600. PubMed ID: 5940924
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical evaluation of the efficacy of a topical preparation containing 2% hydroquinone in chloasma].
    Melli MC
    G Ital Dermatol Venereol; 1987 Dec; 122(12):LXV-LXVII. PubMed ID: 3447991
    [No Abstract]   [Full Text] [Related]  

  • 11. [Irreversible toxic depigmentation. Observations following use of hydroquinonemonobenzylether-containing skin bleaching preparations].
    Heilgemeir GP; Balda BR
    MMW Munch Med Wochenschr; 1981 Jan; 123(2):47-8. PubMed ID: 6782448
    [No Abstract]   [Full Text] [Related]  

  • 12. A randomized and placebo-controlled study to compare the skin-lightening efficacy and safety of lignin peroxidase cream vs. 2% hydroquinone cream.
    Mauricio T; Karmon Y; Khaiat A
    J Cosmet Dermatol; 2011 Dec; 10(4):253-9. PubMed ID: 22151932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience in the treatment of hyperpigmentation of facial skin with hydroquinone monobenzyl ether].
    Gusarova AS; Zalem ZIa
    Vestn Dermatol Venerol; 1966 Mar; 40(3):49-52. PubMed ID: 5988245
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of melanin-induced pigment anomalies].
    Herzberg JJ
    Hautarzt; 1985 Nov; 36(11):635-8. PubMed ID: 3908403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical use of hydroquinone as a depigmenting agent.
    Arndt KA; Fitzpatrick TB
    JAMA; 1965 Nov; 194(9):965-7. PubMed ID: 5897965
    [No Abstract]   [Full Text] [Related]  

  • 16. Probable coexisting exogenous ochronosis and mercurial pigmentation managed by dermabrasion.
    Lang PG
    J Am Acad Dermatol; 1988 Nov; 19(5 Pt 2):942-6. PubMed ID: 3192777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin bleaching: highlighting the misuse of cutaneous depigmenting agents.
    Dadzie OE; Petit A
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):741-50. PubMed ID: 19470077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Letter: Lasting depigmentation caused by hydroquinonemonobenzylether].
    Fitzpatrick B
    Hautarzt; 1975 Jan; 26(1):56. PubMed ID: 1116947
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of nonhairy melanocytic macules by dermabrasion and topical application of 5% hydroquinone monobenzyl ether cream.
    Tezuka T; Saheki M; Kusuda S; Umemoto K
    J Am Acad Dermatol; 1993 May; 28(5 Pt 1):771-2. PubMed ID: 8496423
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydroquinone: myths and reality.
    Searle T; Al-Niaimi F; Ali FR
    Clin Exp Dermatol; 2021 Jun; 46(4):636-640. PubMed ID: 33159818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.